Author
Listed:
- Johan F. A. Pijnenborg
(Radboud University)
- Emiel Rossing
(Radboud University)
- Jona Merx
(Radboud University)
- Marek J. Noga
(Radboud University Medical Center)
- Willem H. C. Titulaer
(Radboud University)
- Nienke Eerden
(Radboud University)
- Raisa Veizaj
(Radboud University Medical Center)
- Paul B. White
(Radboud University)
- Dirk J. Lefeber
(Radboud University Medical Center
Radboud University Medical Center)
- Thomas J. Boltje
(Radboud University)
Abstract
The sugar fucose is expressed on mammalian cell membranes as part of glycoconjugates and mediates essential physiological processes. The aberrant expression of fucosylated glycans has been linked to pathologies such as cancer, inflammation, infection, and genetic disorders. Tools to modulate fucose expression on living cells are needed to elucidate the biological role of fucose sugars and the development of potential therapeutics. Herein, we report a class of fucosylation inhibitors directly targeting de novo GDP-fucose biosynthesis via competitive GMDS inhibition. We demonstrate that cell permeable fluorinated rhamnose 1-phosphate derivatives (Fucotrim I & II) are metabolic prodrugs that are metabolized to their respective GDP-mannose derivatives and efficiently inhibit cellular fucosylation.
Suggested Citation
Johan F. A. Pijnenborg & Emiel Rossing & Jona Merx & Marek J. Noga & Willem H. C. Titulaer & Nienke Eerden & Raisa Veizaj & Paul B. White & Dirk J. Lefeber & Thomas J. Boltje, 2021.
"Fluorinated rhamnosides inhibit cellular fucosylation,"
Nature Communications, Nature, vol. 12(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-27355-9
DOI: 10.1038/s41467-021-27355-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-27355-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.